Diisopropylethylamine → N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]thieno[3,2-b]pyridine-2-carboxamide
反応式
[S:1]1[C:9]2[C:4](=[N:5][CH:6]=[CH:7][CH:8]=2)[CH:3]=[C:2]1[C:10]([OH:12])=O.CN(C(ON1N=[N:28][C:23]2[CH:24]=[CH:25][CH:26]=[N:27][C:22]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH:37](N(CC)C(C)C)(C)[CH3:38]>CN(C=O)C>[N:27]12[CH2:26][CH2:25][CH:24]([CH2:37][CH2:38]1)[C@@H:23]([NH:28][C:10]([C:2]1[S:1][C:9]3[C:4](=[N:5][CH:6]=[CH:7][CH:8]=3)[CH:3]=1)=[O:12])[CH2:22]2参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
35 mg (0.20 mmol) of thieno[3,2-b]pyridine-2-carboxylic acid, 58.3 mg (0.29 mmol) of R-3-aminoquinuclidine dihydrochloride, 111.4 mg (0.29 mmol) of HATU, 138.8 mg (1.07 mmol) of N,N-diisopropylethylamine and 1.5 ml of DMF are reacted according to the general procedure (variant A). The reaction mixture is purified by preparative HPLC and then subjected to fine purification on silica gel 60 (mobile phase: dichloromethane/methanol/ammonia 90:9:1). 44 mg (78% of theory) of the title compound are isolated.
後処理
- customThe reaction mixture is purified by preparative HPLC
- customsubjected to fine purification on silica gel 60 (mobile phase: dichloromethane/methanol/ammonia 90:9:1)
出典と根拠
- ORDレコード
- ord-1544df56cb9547588d2f2025cb2ddd18
- 出典データセット
- uspto-grants-2011_12
- 特許番号
- US08076355B2
反応ノート
読み込み中…